Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 18/20 | 0.70 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.70 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.59 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.59 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | HTR1A | P08908 | 1/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.59 |
| ▸ | DRD3 | P35462 | 1/20 | 0.59 |
| ▸ | HTR2B | P41595 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27881453 | 1.00 | ADRB2 (0.70) | ADRB2ADRB1ADRB3CYP2D6ADRA2A | |
| SCHEMBL14389155 | 0.87 | ADRB2 (0.77) | ADRB2ADRB1ADRB3 | |
| SCHEMBL119853 | 0.83 | ADRB2 (0.74) | ADRB2ADRB1ADRB3 | |
| SCHEMBL5006903 | 0.82 | ADRB2 (1.00) | ADRB2ADRB1ADRA1D | |
| SCHEMBL4867689 | 0.82 | ADRB2 (1.00) | ADRB2ADRB1ADRA1D | |
| SCHEMBL4889035 | 0.82 | ADRB2 (1.00) | ADRB2ADRB1ADRA1D | |
| SCHEMBL4862750 | 0.82 | ADRB2 (1.00) | ADRB2ADRB1ADRA1D | |
| SCHEMBL4867697 | 0.82 | ADRB2 (1.00) | ADRB2ADRB1ADRA1D | |
| SCHEMBL14505292 | 0.82 | ADRB2 (1.00) | ADRB2ADRB1ADRB3KDM4EGAA | |
| SCHEMBL11565661 | 0.82 | ADRB2 (0.56) | ADRB2ADRB1ADRB3CYP2D6ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090298742-A1 | PROCESS FOR MANUFACTURING LACTOSE | GLAXO GROUP LIMITED (GB) | 2009-12-03 | — | — | US | claimed |
| US-20090291146-A1 | PROCESS FOR MANUFACTURING LACTOSE | GLAXO GROUP LIMITED | 2009-11-26 | — | — | US | claimed |
| EP-2049086-A2 | PROCESS FOR MANUFACTURING LACTOSE | Glaxo Group Limited (GB) | 2009-04-22 | — | — | EP | claimed |
| WO-2008021142-A2 | PROCESS FOR MANUFACTURING LACTOSE | GLAXO GROUP LIMITED (GB) | 2008-02-21 | — | — | WO | claimed |
| WO-2006124556-A2 | INHALABLE PHARMACEUTICAL FORMULATIONS EMPLOYING LACTOSE ANHYDRATE AND METHODS OF ADMINISTERING THE SAME | GLAXO GROUP LIMITED (GB) | 2006-11-23 | — | — | WO | claimed |
| EP-3199164-B1 | PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM | GLAXO GROUP LTD (GB) | 2020-03-18 | — | — | EP | disclosed |
| EP-3199164-A1 | PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM | Glaxo Group Limited (GB) | 2017-08-02 | — | — | EP | disclosed |
| EP-1848444-B1 | PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM | GLAXO GROUP LTD (GB) | 2016-11-09 | — | — | EP | disclosed |
| US-9365905-B2 | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom | DMV-FONTERRA EXCIPIENTS TECHNOLOGY GMBH (DE) | 2016-06-14 | — | — | US | disclosed |
| WO-2011069197-A1 | INHALABLE FORMULATIONS | THE UNIVERSITY OF SYDNEY (AU) | 2011-06-16 | — | — | WO | disclosed |
| US-20100148091-A1 | METHOD AND SYSTEM FOR RAPID PHASE LUMINESCENSE SPECTROSCOPY ANALYSIS | GLAXO GROUP LIMITED | 2010-06-17 | — | — | US | disclosed |
| US-20100116033-A1 | DRY POWDER RHEOMETER | GLAXO GROUP LIMITED (GB) | 2010-05-13 | — | — | US | disclosed |
| EP-1858528-A2 | PROCESS FOR CRYSTALLIZING LACTOSE PARTICLES FOR USE IN PHARMACEUTICAL FORMULATIONS | GLAXO GROUP LIMITED (GB) | 2007-11-28 | — | — | EP | disclosed |
| US-20070257202-A1 | Luminescence Sensor Apparatus and Method | GLAXO GROUP LIMITED | 2007-11-08 | — | — | US | disclosed |
| EP-1848444-A1 | PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM | GLAXO GROUP LIMITED (GB) | 2007-10-31 | — | — | EP | disclosed |
| EP-1836452-A2 | APPARATUS AND METHOD FOR MEASURING THE ACCELERATION IMPARTED ON METERED DOSE DELIVERY CONTAINERS | SmithKline Beecham Corporation (US) | 2007-09-26 | — | — | EP | disclosed |
| WO-2007076315-A2 | AEROSOL CANISTER EMPLOYING A POLYMERIC FILM HAVING IMPROVED MOISTURE BARRIER PROPERTIES | GLAXO GROUP LIMITED (GB) | 2007-07-05 | — | — | WO | disclosed |
| WO-2006086270-A1 | PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM | GLAXO GROUP LIMITED (GB) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006086130-A2 | PROCESS FOR CRYSTALLIZING LACTOSE PARTICLES FOR USE IN PHARMACEUTICAL FORMULATIONS | GLAXO GROUP LIMITED (GB) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006076221-A2 | APPARATUS AND METHOD FOR MEASURING THE ACCELERATION IMPARTED ON METERED DOSE DELIVERY CONTAINERS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-07-20 | — | — | WO | disclosed |